One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: A Prespecified Analysis of the SWISS-APERO Randomized Clinical Trial

Affiliations

• ¹ Departments of Cardiology (R.G., C.G., L.R., M.V.), CTU Bern, University of Bern, Switzerland.
• ² Besancon University Hospital, University of Burgundy Franche-Comté, Besancon, France (N.M.).
• ³ Department of Cardiology, Monzino Cardiology Center, Milan, Italy (F.D.M.).
• ⁴ Department of Cardiology, Centre Hospitalier Universitaire de Charleroi, Belgium (A.A.).
• ⁵ Bern University Hospital, and Department of Clinical Research (D.H., K.C.), CTU Bern, University of Bern, Switzerland.
• ⁶ Department of Cardiology, University Hospital of Rouen, France (F.A.).
• ⁷ Department of Advanced Biomedical Sciences, University Federico II University, Naples, Italy (A.F.).
• ⁸ Department of Cardiology and Critical Care Medicine, Hartcentrum Hasselt, Jessa Ziekenhuis, Hasselt, Belgium (P.V.).
• ⁹ Faculty of Medicine and Life Sciences, Hasselt University, Belgium (P.V.).
• ¹⁰ Neurology (U.F.), CTU Bern, University of Bern, Switzerland.
• ¹¹ Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy (F.B.).
• ¹² Cardiocentro Ticino Institute and Università della Svizzera Italiana (USI), Lugano, Switzerland (M.V.).